Marinus Pharmaceuticals I... (MRNS)
NASDAQ: MRNS
· Real-Time Price · USD
0.55
0.00 (0.00%)
At close: Feb 10, 2025, 3:59 PM
Marinus Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -140.49M | -149.24M | -145.34M | -141.41M | -133.95M | -27.69M | -35.19M | -19.82M | -13.81M | -106.61M | -91M | -98.78M | -87.94M | -84.09M | -75.94M |
Depreciation & Amortization | -488K | 538K | 525K | 551K | 508K | 524K | 490K | 418K | 429K | 362K | 355K | 355K | 356K | 338K | 335K |
Stock-Based Compensation | 18.86M | 18.04M | 17.02M | 15.56M | 15.44M | 15.33M | 15.25M | 14.89M | 14.09M | 13.04M | 12.21M | 13.87M | 12.99M | 12M | 10.8M |
Other Working Capital | 4.68M | 4.34M | 5.33M | 9.18M | 12.1M | 10.4M | 8.75M | -4.99M | -15.34M | 5.83M | 2.83M | 16.39M | 155.08M | 131.78M | 131.89M |
Other Non-Cash Items | 13.36M | 12.85M | 12.09M | 4.4M | 7.34M | 5.7M | 4.25M | 4.98M | 3.06M | 3.23M | 3.13M | 1.06M | 903K | 737K | 624K |
Deferred Income Tax | 1.49M | 1.17M | 724K | 724K | -768K | -441K | n/a | n/a | -687K | -687K | -687K | -687K | n/a | 1K | 2K |
Change in Working Capital | 230K | 3.89M | 8.73M | 2.17M | -1.5M | -3.55M | -4.25M | -6.09M | -8.54M | 12.98M | 9.04M | 28.7M | 23.57M | 1.02M | 1.13M |
Operating Cash Flow | -114.75M | -120.47M | -113.98M | -118M | -112.92M | -117.39M | -126.71M | -112.89M | -112.72M | -77.67M | -66.96M | -55.48M | -50.13M | -70M | -63.05M |
Capital Expenditures | -1.19M | -157K | -119K | -119K | -177K | -1.35M | -1.69M | -1.77M | -2.4M | -2.01M | -2.54M | -2.89M | -612K | 260K | 1.13M |
Cash Acquisitions | -9K | -4K | n/a | n/a | 180K | 175K | 171K | 171K | n/a | n/a | n/a | n/a | n/a | n/a | -1K |
Purchase of Investments | 5K | n/a | n/a | -51.99M | -52.17M | -52.17M | -52.17M | -171K | n/a | n/a | n/a | n/a | -8.93M | -17.86M | -18.36M |
Sales Maturities Of Investments | 36.38M | 48.38M | 44.38M | 23.5M | -90.38M | 5M | n/a | n/a | 107.38M | n/a | n/a | 1.47M | 3.96M | 6.94M | 7.93M |
Other Investing Acitivies | 27.39M | 27.39M | 32.39M | -40.49M | 60.56M | 167.93M | 162.93M | 214.92M | 105.58M | -1.79M | -1.79M | -319K | 8.85M | 17.78M | 17.78M |
Investing Cash Flow | 35.2M | 48.23M | 44.27M | -28.61M | -34.99M | 59.2M | 53.86M | 105.77M | 104.97M | -2.01M | -2.54M | -1.42M | 1.79M | 5.64M | 7M |
Debt Repayment | -1.19M | 737K | 737K | 737K | 29.63M | 29.07M | 29.07M | 58.47M | 28.84M | 57.38M | 69.66M | 40.26M | 40.26M | 12.28M | n/a |
Common Stock Repurchased | -76K | -76K | -76K | -76K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -17.44M | 8.46M | 26.4M | 25.97M | 90.47M | 64.59M | 64.36M | 66.27M | 2.06M | 2.15M | 2.13M | 494K | 601K | 500K | 44.62M |
Financial Cash Flow | -18.7M | 9.12M | 27.06M | 26.63M | 120.1M | 93.65M | 93.43M | 124.74M | 30.9M | 59.52M | 72.35M | 41.31M | 106.1M | 77.92M | 109.19M |
Net Cash Flow | -98.25M | -63.11M | -42.65M | -119.98M | -27.81M | 35.46M | 20.59M | 117.62M | 23.15M | -20.17M | 2.85M | -15.58M | 57.76M | 13.56M | 53.15M |
Free Cash Flow | -115.93M | -120.62M | -114.1M | -118.12M | -113.1M | -118.75M | -128.4M | -114.66M | -115.13M | -79.69M | -69.5M | -58.37M | -50.74M | -69.74M | -61.92M |